Skip to main content

About Us

Meet the people behind Variant Bio

Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.

Team photo with all Variant Bio staff at a retreat. All fifty people looking at the camera, smiling
A headshot of David McElligot

David McElligott, PhD

Former CSO, Petra Pharma

A headshot of Evan Eichler

Evan Eichler, PhD

Professor of Genome Sciences, HHMI Investigator, University of Washington

A headshot of Gosia Trynka

Gosia Trynka, PhD

Group Leader, Wellcome Sanger Institute, Experimental Science Director, Open Targets

A headshot of Karen Akinsanya

Karen Akinsanya, PhD

Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, Schrödinger

A headshot of Rob Scott

Rob Scott, MD

Former CMO, Abbvie

A headshot of Ryan Hernandez

Ryan Hernandez, PhD

Professor of Bioengineering and Therapeutic Sciences, UC San Francisco

A headshot of Tuuli Lappalainen

Tuuli Lappalainen, PhD

Professor, KTH Royal Institute of Technology, Senior Associate Member, New York Genome Center

Our Investors

Logo for Venture Investments
Logo for Alta Parners
Logo for Casdin Capital
Logo for Lux
Logo for Sahsen
Logo for Softbank

We are at the cutting edge of genomic drug discovery.

Careers at Variant Bio